TBPH · Theravance Biopharma, Inc. · Debt
Market Cap
$886.77M
Shares
51.92M
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Key facts
CIK
1583107
CUSIP
G8807B106
13F (30d)
119 filings
118 filers
Visit website
Investor relations